| Samrat Pharmachem Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530125 |
NSE Symbol : - |
P/E(TTM) : 49.86 |
|
ISIN Demat : INE103E01016 |
Div & Yield% : 0.39 |
EPS(TTM) : 5.08 |
|
Book Value(₹) : 228.74 |
Market Cap(₹Cr) : 78.26 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 78.87 | 75.65 | 71.20 | 63.66 | 70.17 | 80.82 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 78.87 | 75.65 | 71.20 | 63.66 | 70.17 | 80.82 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.05 | 0.69 | -0.11 | 0.00 | 0.49 | 0.59 |
| Total Income | 78.92 | 76.34 | 71.10 | 63.67 | 70.66 | 81.41 |
| Total Expenditure | 79.23 | 75.53 | 71.08 | 59.49 | 66.81 | 78.24 |
| PBIDT | -0.31 | 0.82 | 0.02 | 4.18 | 3.85 | 3.17 |
| Interest | 0.26 | 0.44 | 0.22 | 0.10 | 0.17 | 0.19 |
| PBDT | -0.57 | 0.38 | -0.20 | 4.08 | 3.69 | 2.98 |
| Depreciation | 0.18 | 0.17 | 0.16 | 0.17 | 0.17 | 0.16 |
| Tax | 0.00 | 0.00 | 0.09 | 0.88 | 1.43 | 0.60 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.16 | 0.44 | -0.05 | 0.25 | -0.57 | 0.15 |
| Reported Profit After Tax | -0.59 | -0.23 | -0.40 | 2.78 | 2.66 | 2.07 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.59 | -0.23 | -0.40 | 2.78 | 2.66 | 2.07 |
| EPS (Unit Curr.) | -1.90 | -0.74 | -1.29 | 9.01 | 8.61 | 6.68 |
| EPS (Adj) (Unit Curr.) | -1.90 | -0.74 | -1.29 | 9.01 | 8.61 | 6.68 |
| Calculated EPS (Unit Curr.) | -1.90 | -0.74 | -1.29 | 9.01 | 8.61 | 6.68 |
| Calculated EPS (Adj) (Unit Curr.) | -1.90 | -0.74 | -1.29 | 9.01 | 8.61 | 6.68 |
| Calculated EPS (Ann.) (Unit Curr.) | -7.60 | -2.96 | -5.17 | 36.05 | 34.45 | 26.74 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -7.60 | -2.96 | -5.17 | 36.05 | 34.45 | 26.74 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -0.39 | 1.08 | 0.03 | 6.57 | 5.49 | 3.92 |
| PBDTM(%) | -0.72 | 0.50 | -0.28 | 6.41 | 5.26 | 3.69 |
| PATM(%) | -0.75 | -0.30 | -0.56 | 4.37 | 3.79 | 2.56 |